MorphoSys AG (MOR)
17.92
+0.02
(+0.11%)
USD |
NASDAQ |
May 03, 13:09
MorphoSys Free Cash Flow
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2023 | -474.15M |
| March 31, 2023 | -533.98M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -685.58M |
| March 31, 2022 | -711.40M |
| December 31, 2021 | -600.58M |
| September 30, 2021 | -497.50M |
| June 30, 2021 | -340.18M |
| March 31, 2021 | -299.64M |
| December 31, 2020 | -16.06M |
| September 30, 2020 | 31.94M |
| June 30, 2020 | 106.93M |
| March 31, 2020 | 163.64M |
| December 31, 2019 | -94.86M |
| September 30, 2019 | -77.51M |
| June 30, 2019 | -45.74M |
| March 31, 2019 | -36.18M |
| December 31, 2018 | -41.62M |
| September 30, 2018 | -16.05M |
| June 30, 2018 | -72.58M |
| March 31, 2018 | -80.48M |
| December 31, 2017 | -58.43M |
| September 30, 2017 | -76.20M |
| June 30, 2017 | -68.99M |
| Date | Value |
|---|---|
| March 31, 2017 | -54.90M |
| December 31, 2016 | -54.82M |
| September 30, 2016 | -55.07M |
| June 30, 2016 | -49.55M |
| March 31, 2016 | -43.06M |
| December 31, 2015 | -35.82M |
| September 30, 2015 | -30.30M |
| June 30, 2015 | -34.89M |
| March 31, 2015 | -36.54M |
| December 31, 2014 | -46.14M |
| September 30, 2014 | -45.86M |
| June 30, 2014 | 99.62M |
| March 31, 2014 | 91.80M |
| December 31, 2013 | 110.99M |
| September 30, 2013 | 125.81M |
| June 30, 2013 | -2.786M |
| March 31, 2013 | 4.078M |
| December 31, 2012 | -0.6701M |
| September 30, 2012 | -13.41M |
| June 30, 2012 | -14.19M |
| March 31, 2012 | 20.20M |
| December 31, 2011 | 32.72M |
| September 30, 2011 | 37.63M |
| June 30, 2011 | 7.146M |
| March 31, 2011 | -17.98M |
Free Cash Flow Range, Past 5 Years
-711.40M
Minimum
Mar 2022
163.64M
Maximum
Mar 2020
-271.65M
Average
-299.64M
Median
Mar 2021
Free Cash Flow Benchmarks
| Incyte Corp | 790.77M |
| Novartis AG | 10.25B |
| Immatics NV | -13.78M |
| Affimed NV | -123.42M |
| InflaRx NV | -41.02M |
Free Cash Flow Related Metrics
| Free Cash Flow Yield | -19.27% |